Pmv Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $1,618 | $0 |
Gross Profit | -372 | -362 | 1,259 | -358 |
EBITDA | -19,798 | -17,859 | -18,543 | -19,628 |
EBIT | -20,170 | -18,221 | -18,902 | -19,986 |
Net Income | -1,213 | -15,270 | -15,756 | -16,640 |
Net Change In Cash | 0 | 0 | 1,618 | 0 |
Free Cash Flow | -1,602 | -16,778 | -12,282 | -15,703 |
Cash | 49,348 | 48,476 | 38,528 | 52,057 |
Basic Shares | 51,478 | 51,445 | 51,445 | 49,047 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1,257 | -650 | -1,281 | -318 |
EBITDA | -78,875 | -76,725 | -57,986 | -34,624 |
EBIT | -80,132 | -77,040 | -58,293 | -34,942 |
Net Income | -68,960 | -73,317 | -57,846 | -34,440 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -64,170 | -188,133 | 288,144 | |
Free Cash Flow | -56,619 | -71,744 | -47,920 | -32,887 |
Cash | 38,528 | 108,297 | 172,467 | 361,422 |
Basic Shares | 48,014 | 45,594 | 45,137 | 44,777 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.02 |
2024-03-31 | -$0.30 |
2023-12-31 | -$0.31 |
2023-09-30 | -$0.34 |
